Bionano Genomics
BNGO
8 hedge funds and large institutions have $67M invested in Bionano Genomics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
87.43% more ownership
Funds ownership: 0% → 87.43% (+87%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$50.6M |
| 2 |
SCM
Sio Capital Management
New York
|
+$10.2M |
| 3 |
Walleye Trading
New York
|
+$674K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$350K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$59.7K |
Top Sellers
BNGO Hedge Fund Activity: Q3 2018 in Review
8 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2018, worth a combined $67M.
Buyers outnumbered sellers: 8 funds opened new BNGO positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Federated Hermes, opening a new position worth an estimated $50.6M.
- 8 institutional investors held Bionano Genomics (BNGO) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $67M of Bionano Genomics stock for Q3 2018.
- 8 funds opened new Bionano Genomics positions in Q3 2018 and 0 closed out, a net change of +8 holders.
- The largest Bionano Genomics buyer in Q3 2018 was Federated Hermes, an estimated $50.6M added.
Based on aggregated 13F filings for Q3 2018.